June 8, 2026

• 4:30 PM · Nikkei Asia
  4:30 PMHong Kong's urban development near China border draws AstraZeneca, others — Nikkei Asia
• 1:35 PM · BioPharma Dive
  1:35 PMRoche stakes $700M on Nurix’s protein-degrading drug — BioPharma Dive
• 12:00 PM · BioWorld
  12:00 PMIncyte nabs potential VWD game-changer in Vega deal; J&J buys Firefly — BioWorld
• 12:00 PM · BioWorld
  12:00 PMClinical footwork pays off in Tango’s PDAC combo phase I/II — BioWorld
• 11:26 AM · BioPharma Dive
  11:26 AMJ&J to acquire Firefly, maker of ‘degrader’ antibody drugs, for up to $1B — BioPharma Dive
• 11:01 AM · BioPharma Dive
  11:01 AMADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option — BioPharma Dive
• 9:17 AM · STAT News
  9:17 AMSTAT+: J&J spends $1 billion to enter KRAS race for cancer treatments — STAT News
• 9:00 AM · BioWorld
  9:00 AMDual ABCB4/ABCB11 modulation shows promise in cholestatic disease models — BioWorld
• 9:00 AM · BioWorld
  9:00 AMGenescience presents data on Gensci-136, a dual BAFF/APRIL inhibitor for SLE — BioWorld
• 9:00 AM · BioWorld
  9:00 AMOnkure Therapeutics patents new PI3Kα mutant inhibitors — BioWorld
• 9:00 AM · BioWorld
  9:00 AMEikon Therapeutics discloses new USP1 inhibitors — BioWorld
• 9:00 AM · BioWorld
  9:00 AMChina’s NMPA clears Hansoh’s HS-10541 for clinic — BioWorld
• 9:00 AM · BioWorld
  9:00 AMLBL-051: Broad immune targeting in autoimmune disease — BioWorld
• 9:00 AM · BioWorld
  9:00 AMATG-207 shows efficacy in EAE with reduced cytokine release — BioWorld
• 9:00 AM · BioWorld
  9:00 AMAmphista’s BRD9 degrader gains IND clearance for AML — BioWorld
• 9:00 AM · BioWorld
  9:00 AMSkape Bio unlocks GPCR targets with de novo-designed miniproteins — BioWorld
• 9:00 AM · BioWorld
  9:00 AMAntares Therapeutics divulges new CDK2/cyclin E1 inhibitors — BioWorld
• 5:25 AM · Pharmaceutical Technology
  5:25 AMSanofi and Owkin partner to develop next-generation biopharma AI agents — Pharmaceutical Technology
• 3:38 AM · Pharmaceutical Technology
  3:38 AMEC grants marketing authorisation for IntraBio’s Aqneursa — Pharmaceutical Technology
• 2:00 AM · Science (News)
  2:00 AMNIH plans to cap number of grants a scientist can have at once — Science (News)
• 1:15 AM · Science (News)
  1:15 AMLeading supplier of research monkeys declares bankruptcy — Science (News)